´ëÇѺ´¸®ÇÐȸ (¿Â¶óÀÎ)2022³âµµ Á¦3Â÷ ¿¬¼ö±³À°(³»ºÐºñº´¸®) : 2022-11-26±³À°ÀÏÀÚ : 2022-11-26
±³À°Àå¼Ò :
www.keymedi.com(¿Â¶óÀο¬¼ö±³À°)
±³À°ÁÖÁ¦ :
(¿Â¶óÀÎ)2022³âµµ Á¦3Â÷ ¿¬¼ö±³À°(³»ºÐºñº´¸®)ÁÖÃÖ±â°ü : ´ëÇѺ´¸®ÇÐȸ
´ã´çÀÚ : ´ëÇѺ´¸®ÇÐȸ
¿¬¶ôó : 02-795-3094
À̸ÞÀÏ :
ksphe@kams.or.kr ±³À°Á¾·ù : º´¸®°ú
Âü¼®¿¹»óÀοø : 200¸í
Èñ¸ÁÆòÁ¡ : 5Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 5 ½Ã°£ 10ºÐ
¼¼ºÎ¼ö°·á : 100,000¿ø
ºñ°í ´ëÇѺ´¸®ÇÐȸ ¹Ì³³È¸ºñ¾ø´Â ȸ¿ø(Àü¹®ÀÇ : 40,000¿ø/Àü°øÀÇ(±ºÀÇ°üÆ÷ÇÔ) : 25,000¿ø), ¹Ì³³È¸ºñ Àִ ȸ¿ø(Àü¹®ÀÇ : 70,000¿ø/Àü°øÀÇ(±ºÀÇ°ü Æ÷ÇÔ) : 50,000¿ø), ºñȸ¿ø Àü¹®ÀÇ(À¯°ü¾÷ü ¶Ç´Â ´Üü¼Ò¼Ó ºñȸ¿ø Æ÷ÇÔ) : 100,000¿ø/ ºñȸ¿ø Àü°øÀÇ(Á¶±³, ´ëÇпø»ý. ±ºÀÇ°üÆ÷ÇÔ) : 50,000¿ø »çÀüµî·Ï :
https://www.pathology.or.kr/html/ ±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 11-26 keymedi.com 10:10~10:40 Overview of the 2022 WHO Classification of Thyroid Neoplasms Á¤Âù±Ç(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 11-26 keymedi.com 10:40~11:10 Case review of thyroid tumors ½Å¼öÁø(¿¬¼¼ÀÇ´ë)
Åä·Ð 11-26 keymedi.com 11:10~11:20 Q & A ()
±³À°½Ã°£ 11-26 keymedi.com 11:20~11:50 Overview of the 2022 WHO Classification of Parathyroid Neoplasms ±è¿µ¾Æ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 11-26 keymedi.com 11:50~12:20 Case review of parathyroid tumors ±ÇÇüÁÖ(¿¬¼¼¿øÁÖÀÇ´ë)
Åä·Ð 11-26 keymedi.com 12:20~12:30 Q & A ()
±³À°½Ã°£ 11-26 keymedi.com 13:30~14:00 Overview of the 2022 WHO Classification of adrenal cortical tumors ¼Ûµ¿Àº(¿ï»êÀÇ´ë)
±³À°½Ã°£ 11-26 keymedi.com 14:00~14:30 Tumors of the adrenal medulla and extra-adrenal paraganglia ¿øÀç°æ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 11-26 keymedi.com 14:30~15:00 Case review of adrenal and extra-adrenal tumors ³ªÈñ¿µ(¼¿ïÀÇ´ë)
Åä·Ð 11-26 keymedi.com 15:00~15:10 Q & A ()
±³À°½Ã°£ 11-26 keymedi.com 15:20~15:50 Familial endocrine syndromes ±èÈñ¼º(Áß¾ÓÀÇ´ë)
±³À°½Ã°£ 11-26 keymedi.com 15:50~16:20 Case review of familial endocrine tumors ½ÅÇüÂù(°è¸íÀÇ´ë)
Åä·Ð 11-26 keymedi.com 16:20~16:30 Q & A ()